Arcus Biosciences RCUS
NYSE RCUS
$19.16 +0.06 (+0.31%)
As of: Oct 22, 2026 · 10:49 AM EDT

Arcus Biosciences (RCUS) Invested Capital (2023 - 2026)

Updated

Analysis

Arcus Biosciences (RCUS) Invested Capital (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Eli Lilly 1,162.99 Bn 1,131.58 Bn 19.71 Bn 88.79 Bn
2 Johnson & Johnson 633.71 Bn 552.23 Bn 17.26 Bn 134.01 Bn
3 AbbVie 502.40 Bn 475.51 Bn 12.70 Bn 64.89 Bn
4 Merck 376.48 Bn 330.86 Bn 12.21 Bn 95.89 Bn
5 Novartis Ag 303.61 Bn 267.60 Bn 11.24 Bn 51.53 Bn
6 Astrazeneca 267.02 Bn 240.70 Bn 12.86 Bn 82.72 Bn
7 Amgen 240.85 Bn 196.25 Bn 7.24 Bn 68.99 Bn
8 Gilead Sciences 193.39 Bn 167.58 Bn 6.22 Bn 38.08 Bn
9 Pfizer 172.14 Bn 118.78 Bn 10.94 Bn 148.69 Bn
10 Arcus Biosciences 2.42 Bn -911.73 Mn - 565.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 565.00 Mn
Mar 31, 2026 624.00 Mn
Dec 31, 2025 730.00 Mn
Sep 30, 2025 534.00 Mn
Jun 30, 2025 646.00 Mn
Mar 31, 2025 579.00 Mn
Dec 31, 2024 533.00 Mn
Sep 30, 2024 612.00 Mn
Dec 31, 2023 462.00 Mn
API Access

Arcus Biosciences Invested Capital API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=invested-capital&ticker=RCUS&period=max&api_key=YOUR_API_KEY